Nationwide Laboratories Phenazopyridine Hydrochloride Tablets, USP, 200 mg, 100 count recall — FDA D-0168-2017
CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures.
Overview of recall records associated with Nationwide Laboratories, LLC, including dates, categories and classifications where available.
Classification mix: Class II: 4.
CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures.
CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures.
CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures.
CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures.
This page summarizes recall records in which the official source identifies Nationwide Laboratories, LLC as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.